New Zealand - English - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - galantamine hydrobromide 20.51mg equivalent to 16 mg galatamine base; galantamine hydrobromide 20.51mg equivalent to 16 mg galatamine base - modified release capsule - 16 mg - active: galantamine hydrobromide 20.51mg equivalent to 16 mg galatamine base excipient: diethyl phthalate ethylcellulose gelatin hypromellose iron oxide red opacode black s-1-27794 opadry clear oy-7240 sugar spheres titanium dioxide active: galantamine hydrobromide 20.51mg equivalent to 16 mg galatamine base excipient: diethyl phthalate ethylcellulose gelatin hypromellose opacode black s-1-277002 opadry clear oy-7240 sugar spheres - reminyl is indicated for the treatment of mild to moderately severe dementia of the alzheimer type.

New Zealand - English - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - galantamine hydrobromide 30.76mg equivalent to galantamine base 24 mg; galantamine hydrobromide 30.76mg equivalent to galantamine base 24 mg - modified release capsule - 24 mg - active: galantamine hydrobromide 30.76mg equivalent to galantamine base 24 mg excipient: diethyl phthalate ethylcellulose gelatin hypromellose iron oxide red iron oxide yellow opacode black s-1-277002 opadry clear oy-7240 sugar spheres titanium dioxide active: galantamine hydrobromide 30.76mg equivalent to galantamine base 24 mg excipient: diethyl phthalate ethylcellulose gelatin hypromellose opacode black s-1-277002 opadry clear oy-7240 sugar spheres - reminyl is indicated for the treatment of mild to moderately severe dementia of the alzheimer type.

New Zealand - English - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - galantamine hydrobromide 10.25mg equivalent to galantamine base 8 mg; galantamine hydrobromide 10.25mg equivalent to galantamine base 8 mg - modified release capsule - 8 mg - active: galantamine hydrobromide 10.25mg equivalent to galantamine base 8 mg excipient: diethyl phthalate ethylcellulose gelatin hypromellose opacode black s-1-27794 opadry clear oy-7240 sugar spheres titanium dioxide active: galantamine hydrobromide 10.25mg equivalent to galantamine base 8 mg excipient: diethyl phthalate ethylcellulose gelatin hypromellose opacode black s-1-277002 opadry clear oy-7240 sugar spheres - reminyl is indicated for the treatment of mild to moderately severe dementia of the alzheimer type.

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - 35075 - adaptor, luer - a single use device that mates two devices together and holds them in a secured sealed locking position.

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - 34994 - dialysate delivery system, haemodialysis, single patient - dialysate delivery system - the intended purpose of the monitors is to prepare the haemodialysis dialysate solution, to deliver the dialysate at the right temperature, conductivity, flow rate and pressure, through the compartment of the dialyser where it is used in the treatment of the patient using this machine.

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - 34994 - dialysate delivery system, haemodialysis, single patient - programmable hospital hardware intended to deliver the dialysate to a single patient using a sterile disposable tubing and dialyser system.

Australia - English - Department of Health (Therapeutic Goods Administration)

vantive pty ltd - 58848 - extracorporeal circuit waste bag, sterile - a sterile flexible container intended to be used for the collection of waste fluids during preparation and processing of an extracorporeal circuit (e.g., haemodialysis, haemofiltration, apheresis, adsorption treatment), including the collection and rinsing of ultrafiltrate fluid which may contain blood components.

Australia - English - Department of Health (Therapeutic Goods Administration)

vantive pty ltd - 60638 - haemodialysis system operation software - mainframe or personal computer (pc) based operating system software (or firmware) that is specific to the central processing unit (cpu) incorporated into a haemodialysis system or haemodialysis system dialysate delivery unit. this includes the software or firmware based programs and routines supplied by the computer manufacturer that drive a specific computer in the performance of its tasks and assists the operators, applications programmers, and programs with various supporting functions. a proprietary name and a "version number" are commonly used to identify different operating system versions.

Australia - English - Department of Health (Therapeutic Goods Administration)

vantive pty ltd - 32109 - haemodialysis system transducer protector - a device that protects the electronics within a dialysis system from exposure to saline or blood products in the fluid pathway.

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - 46997 - therapeutic plasma exchange system - the device is intended for extracorporeal blood purification technique designed for the removal of large molecular weight pathological substances from the plasma